AXPLORA
LIVE

Serial Number

79364601

Owner

Axplora Group GmbH

Attorney

B. Michelle Alvey

Filing Date

Nov 30, 2022

Add to watchlist:

No watchlists yet
View on USPTO

AXPLORA Trademark

Serial Number: 79364601 • Registration: 7813324

AXPLORA is a trademark filed by Axplora Group GmbH on November 30, 2022. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Axplora Group GmbH (3 trademarks)

Hochstraß Süd 7

Entity Type: 27

Trademark Details

Filing Date

November 30, 2022

Registration Date

June 3, 2025

Published for Opposition

April 15, 2025

Goods & Services

Pharmaceutical, veterinary, sanitary products, namely, steroids, diuretic preparations, anti-inflammatory preparations, dietary supplements, nutritional supplements, diagnostic agents for medical purposes being visualization agents for use during colonoscopies, contraceptive preparations, preparations for the treatment of burns, pharmaceutical preparations for the treatment of primary biliary cirrhosis in the nature of a cholelitholytic agent, pharmaceutical preparations and substances for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, oncological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; fungicides, herbicides, insecticides, and pesticides

Purified essential oil extracts for use in the pharmaceutical, cosmetics, agrochemistry, food, and polymers industries

Providing quality control, namely, analytic control and authentication services for others; conducting of technical feasibility studies; technical and scientific research and development on new and existing products, notably for the food, chemical, agriculture, veterinary, pharmaceutical industries; scientific research and development in the field of performance of chemical synthesis for others; biological research, namely, synthesis of biological products for clients operating in the food, chemical, agriculture, veterinary, pharmaceutical fields; scientific research and development in the field of synthesis of intermediate products, notably of intermediate organic products for industrial purposes, notably for the food, chemical, agriculture, veterinary, pharmaceutical industries; scientific research and development in the field of synthesis of hazardous products, synthesis of substitution aromates and chiral molecules, notably synthesis of products for others; scientific research in the field of into galenic forms, specifically for others; preparation of galenic formulations, specifically for others

Custom manufacturing of pharmaceutical and chemicals and their components; contract and toll custom manufacturing in the fields of pharmaceuticals, chemicals and biotechnology; preparation and transformation being custom manufacture of vaccine adjuvants, vaccines, proteins, semi-synthetic molecules, conjugated molecules, nucleic acids, polysaccharides and other therapeutic biomolecules; preparation and transformation being custom manufacture on a pilot and commercial scale of vaccine adjuvants, vaccines, proteins, semi-synthetic molecules, conjugated molecules, nucleic acids, polysaccharides, and other therapeutic biomolecules; preparation being processing of functional food and food ingredients; pilot and commercial scale preparation being processing of functional food and food ingredients; preparation and transformation being custom manufacture of chemical products, active pharmaceutical ingredients and synthetic intermediates, and agrochemical active ingredients and synthetic intermediates; preparation and transformation being custom manufacture on a pilot and commercial scale of chemical products, active pharmaceutical ingredients and synthetic intermediates, and agrochemical active ingredients and synthetic intermediates

Chemical products in the nature of chemicals for use in industry and science, specifically for the pharmaceutical, cosmetics, agrochemistry, food, and polymers industries; biochemical catalysts, catalysts for chemical and biochemical processes, catalysts for use in the manufacture of industrial chemicals; chemical additives, chemical additives for use in the manufacture of food, chemical additives for use in the manufacture of pharmaceuticals, chemical additives for use in the manufacture of cosmetics, chemical additives for gasoline; biochemical reagents used for non-medical purposes, chemical reagents, other than for medical or veterinary purposes, reagents for scientific and research use, research reagents for industrial use, namely, for food testing, chemical diagnostic reagents for industrial use; intermediate products of synthesis, namely, chemicals used in industry, namely, intermediate products for the cosmetic, pharmaceutical, agrochemistry, food, and polymers industries; active principles, namely, active chemical ingredients for use in the manufacture of pharmaceuticals, agrochemicals, and explosives; fertilizers; all of the foregoing for use in the pharmaceutical, cosmetics, agrochemistry, food, and polymers industries; intermediary products for the synthesis of pharmaceutical, veterinary, sanitary and cosmetic active principles, namely, chemical products being synthesized pharmaceutical intermediates for the production of active pharmaceutical ingredients used in the manufacture of pharmaceuticals

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 12, 2026 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Dec 30, 2025 XXSS
GENERIC MADRID TRANSACTION CREATED
Dec 30, 2025 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 3, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 3, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 3, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 15, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 15, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 9, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 17, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 7, 2025 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Dec 19, 2024 NREP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 23, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 29, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 29, 2024 OPNR
NEW REPRESENTATIVE AT IB RECEIVED
Sep 13, 2024 NREP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 7, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 7, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 7, 2024 CNRT
EXAMINER'S AMENDMENT ENTERED
Jun 10, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 10, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 10, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 10, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 2, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 2, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 2, 2024 TROA
REFUSAL PROCESSED BY IB
Oct 25, 2023 RFNT
CHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 6, 2023 ADCH
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 2, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 2, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 20, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 19, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 9, 2023 DOCK
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Aug 6, 2023 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
Jun 5, 2023 CRCV
APPLICATION FILING RECEIPT MAILED
Mar 14, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 9, 2023 REPR